Mendoza MDL, Acuña CL, De la Cruz LF, Lagares GA, Varela PL

Language: Spanish
References: 10
Page: 242-248
PDF size: 141.38 Kb.

ABSTRACT

Introduction: antimalarial drug resistance hinders the control of malaria in Colombia. The molecular surveillance of point mutations in therapeutic targets is essential in the study of antimalarial drugs.
Objective: to identify point mutations at dihydropteroate synthetase gene of Plasmodium falciparum (pfdhps) associated with sulfadoxine resistance.
Methods: source of P. falciparum DNA was blood thick smears of 55 individuals with malaria infection, reported in Bolivar, Colombia. The DNA was extracted with 5 %. Chelex-100 solution. The mutations were identified by PCR-RFLP and sequencing.
Results: seventeen samples (31 %) amplified a 438 bp fragment of pfdhps. The PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) showed a frequency of mutant genotype (G-437) in 65 % of amplicons, mixed genotype (A/G-437) in 29 % and wild genotype (A/G-437) in 6 %. The mutant alleles G-437, F-436 and the wild allele K-540 were identified in all sequenced samples.
Conclusions: this is the first report of point mutations in the P. falciparum dhps gene in Bolivar, Colombia. This result contributes to the knowledge of antimalarial drug resistance in the Colombian Caribbean region.

REFERENCES

1. Padilla JC, Álvarez G, Montoya R, Chaparro P, Herrera S. Epidemiology and control of malaria in Colombia. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2011;106:114-22.

2. Espinal CA, Uribe LM, Eslava A, Rodríguez ME. Resistencia del Plasmodium falciparum a la combinacion sulfa-pirimetamina: descripción de los tres primeros casos en Colombia. Biomédica. 1981;1:213-7.

3. Galindo JA, Cristiano FA, Knudson A, Nicholls RS, Guerra AP. Mutaciones puntuales en los genes dhfr y dhps de Plasmodium falciparum de tres regiones endémicas para malaria en Colombia. Biomédica. 2010;30:56-64.

4. Corredor V, Murillo C, Echeverry DF, Benavides J, Pearce RJ, Roper C, et al. Origin and dissemination across the Colombian Andes mountain range of sulfadoxine - pyrimethamine resistance in Plasmodium falciparum. Antimicrob Agents Chemother. 2010;54:3121-5.

5. Villa A, Carmona-Fonseca J, Benito A, Martínez A, Maestre A. Status of dhps and dhfr genes of Plasmodium falciparum in Colombia before artemisinin based treatment policy. Infectio. 2012;16:37-44.

6. Ministerio de Salud, República de Colombia. Resolución 8430 de 1993: por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud [citado 10 Ene 2013]. Disponible en: http://www.minsalud.gov.co/Normatividad/RESOLUCION%208430%20DE% 201993.pdf

7. Van Der Zanden AG, Te Koppele-Vije EM, Vijaya Bhanu N, Van Soolingen D, Schouls LM. Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampicin resistance and spoligotyping of Mycobacterium tuberculosis. J Clin Microbiol. 2003;41:1101-8.

8. Duraisingh M, Curtis J, Warhurst, D. Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol. 1998;89:1-8.

9. Kimura M, Kaneko O, Inoue A, Ishii A, Tanabe K. Amplification by polymerase chain reaction of Plasmodium falciparum DNA from Giemsa-stained thin blood smears. Mol Biochem Parasitol. 1995;70:193-7.

10. Edoh D, Steiger S, Genton B, Beck HP. PCR amplification of DNA from malaria parasites on fixed and stained thick and thin blood films. Trans R Soc Trop Med Hyg. 1997;91:361-3.